| SpectraBase Spectrum ID |
cZwh8TbVKi |
| Name |
1,4-Di-(3-Trifluoromethylbenzyl)-2-methylpiperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
416.168717694 u |
| Formula |
C21H22F6N2 |
| InChI |
InChI=1S/C21H22F6N2/c1-15-12-28(13-16-4-2-6-18(10-16)20(22,23)24)8-9-29(15)14-17-5-3-7-19(11-17)21(25,26)27/h2-7,10-11,15H,8-9,12-14H2,1H3 |
| InChIKey |
YKUKRDURIYSYLI-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
416.411 g/mol |
| Nominal Mass |
416 u |
| Quality |
990 |
| Retention Index |
2136 |
| SMILES |
C(C1=CC(CN2C(CN(CC=3C=C(C(F)(F)F)C=CC3)CC2)C)=CC=C1)(F)(F)F |
| SPLASH |
splash10-0a4i-3960000000-b3da0bf1160b39ee2f47 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1,4-di-(3-Trifluoromethylbenzyl)-2-methyl
2-methyl-1,4-bis(3-(trifluoromethyl)benzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011213 |
